Downregulation of the CDH1 gene and the chromosomal deletion of the 4q and 16q arms were associated with the transcriptional activation of downstream targets of the Wnt and p53/RB pathways, respectively, during HCC progression. The gene discussed is TP53; the disease is hepatocellular carcinoma.